Pfizer
Nana Danso has a diverse work experience spanning over two decades. Nana currently works at Pfizer as the US Ritlecitinib Marketing Lead since September 2022. Prior to this role, they held various positions at Pfizer including Senior Director, Rheumatology Team Lead and Lead, HCP Marketing Director. Before joining Pfizer, they worked at Purdue Pharma L.P. as an Associate Director, Managed Markets, where they developed payer access strategies for pain products. Nana'searlier experience includes roles at Boehringer Ingelheim Pharmaceuticals, Principal Financial Group, Travelers Life & Annuity, and the Connecticut Department of Transportation. At Boehringer Ingelheim Pharmaceuticals, they served as an Associate Director, Managed Markets Marketing, and also had a project manager role in the Managed Markets Marketing department. Before that, they were part of the Management Rotation Program at Boehringer Ingelheim Pharmaceuticals, where they gained exposure to various functional areas within the commercial organization. Nana Danso's work experience highlights their expertise in marketing, managed markets, and strategic planning. Nana has demonstrated success in leading teams, developing strategies, and achieving business results.
Nana Danso obtained a Bachelor of Arts degree in Mathematics from Wesleyan University between 1995 and 1999. Later, between 2003 and 2005, Nana pursued a Master of Business Administration degree at Yale School of Management, focusing on Business, Management, Marketing, and Finance.
This person is not in any teams
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.